Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Condition:   Neovascular (Wet) Age-Related Macular Degeneration Interventions:   Drug: aflibercept;   Drug: High-Dose aflibercept Sponsors:   Regeneron Pharmaceuticals;   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials